Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
15.62
-0.30 (-1.88%)
At close: Apr 28, 2026, 4:00 PM EDT
15.80
+0.18 (1.15%)
Pre-market: Apr 29, 2026, 7:40 AM EDT

Corvus Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-15.28-62.29-27.03-41.31-43.24
Upgrade
Depreciation & Amortization
0.110.090.150.370.46
Upgrade
Loss (Gain) From Sale of Assets
--0.01--0.02-
Upgrade
Loss (Gain) From Sale of Investments
-1.35-1.14-0.89-0.170.24
Upgrade
Loss (Gain) on Equity Investments
1.963.25.2810.014.83
Upgrade
Stock-Based Compensation
5.3332.152.694.23
Upgrade
Other Operating Activities
-27.1433.38---
Upgrade
Change in Accounts Receivable
0.04-0.050.56-0.08-0.51
Upgrade
Change in Accounts Payable
-0.091.06-0.450.41-1.9
Upgrade
Change in Other Net Operating Assets
3.63-2.66-3.711.08-0.83
Upgrade
Operating Cash Flow
-32.8-25.42-23.94-27.02-36.72
Upgrade
Capital Expenditures
-0.17--0.03-0.27-0.01
Upgrade
Sale of Property, Plant & Equipment
-0.01-0.02-
Upgrade
Investment in Securities
-7.62-27.4915.58-23.0321.57
Upgrade
Investing Cash Flow
-7.8-27.4815.54-23.2821.56
Upgrade
Issuance of Common Stock
36.4335.067.86-62.16
Upgrade
Other Financing Activities
-13.97---
Upgrade
Financing Cash Flow
36.4349.037.86-62.16
Upgrade
Net Cash Flow
-4.16-3.88-0.54-50.347
Upgrade
Free Cash Flow
-32.97-25.42-23.97-27.29-36.72
Upgrade
Free Cash Flow Per Share
-0.41-0.42-0.50-0.59-0.88
Upgrade
Levered Free Cash Flow
-46.8613.96-15.79-15.82-22.52
Upgrade
Unlevered Free Cash Flow
-46.8613.96-15.79-15.82-22.52
Upgrade
Change in Working Capital
3.58-1.65-3.591.41-3.24
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.